-transparent.png){kind=logo}
1 We have assessed the efficacy of Viskaldix, a combination of pindolol 10 mg and clopamide 5 mg using continuous intra-arterial ambulatory blood pressure monitoring. 2 Fourteen of the sixteen patients entered were studied on no therapy and following a minimum of 6 weeks at a constant dosage of Viskaldix. 3 Viskaldix produced a marked and consistent reduction of the blood pressure over the 24 h. The diurnal variation in the heart rate was decreased. 4 The results were compared with those of a similar study with once-daily pindolol where there was control during the day but not in the early morning when the blood pressures rose rapidly.
Related Publications
B A Gould, and
R S Hornung, and
H Kieso, and
S Mann, and
E B Raftery
August 1981,
Medizinische Klinik,
B A Gould, and
R S Hornung, and
H Kieso, and
S Mann, and
E B Raftery
February 1979,
British medical journal,
B A Gould, and
R S Hornung, and
H Kieso, and
S Mann, and
E B Raftery
January 1979,
British medical journal,
B A Gould, and
R S Hornung, and
H Kieso, and
S Mann, and
E B Raftery
February 1979,
British medical journal,
B A Gould, and
R S Hornung, and
H Kieso, and
S Mann, and
E B Raftery
February 1979,
British medical journal,
B A Gould, and
R S Hornung, and
H Kieso, and
S Mann, and
E B Raftery
March 1979,
British medical journal,
B A Gould, and
R S Hornung, and
H Kieso, and
S Mann, and
E B Raftery
July 1979,
Lancet (London, England),
B A Gould, and
R S Hornung, and
H Kieso, and
S Mann, and
E B Raftery
May 1981,
Therapie der Gegenwart,
B A Gould, and
R S Hornung, and
H Kieso, and
S Mann, and
E B Raftery
August 1981,
British journal of clinical pharmacology,
B A Gould, and
R S Hornung, and
H Kieso, and
S Mann, and
E B Raftery
February 1990,
The American journal of cardiology,
